Specific multinutrient combination benefits patients with early stage Alzheimer’s disease

A new longitudinal study has shown that a nutritional drink designated a “food for special medical purposes” containing the multinutrient combination Fortasyn Connect can benefit patients with the earliest stages of Alzheimer’s disease (AD), mild cognitive impairment, who are at risk of progressing to the dementia stage of AD, report scientists in the Journal of Alzheimer’s Disease Reports. The purpose […]

Read more

Drug combination makes cancer disappear in mice with neuroblastoma

Researchers investigating new treatments for neuroblastoma—one of the most common childhood cancers—have found that a combination of two drugs made tumours disappear in mice, making it more effective than any other drugs tested in these animals. Professor Murray Norris, deputy director of the Children’s Cancer Institute Australia for Medical Research, Sydney, Australia, told the 30th EORTC-NCI-AACR Symposium on Molecular Targets […]

Read more